Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.14764 | 47 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.11351 | 47 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.11442 | 47 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.04473 | 47 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.23203 | 52 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.31381 | 51 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.14405 | 46 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.08358 | 46 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.05124 | 46 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.09723 | 47 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.09689 | 47 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.08097 | 47 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.13036 | 47 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.18816 | 50 |